Background. Panton-Valentine leukocidin (PVL) is mainly associated with necrotic suppurative lesions, such as furuncles and abscesses in the skin and subcutaneous tissue, but it has also been isolated from patients with community-acquired, severe, necrotizing pneumonia. However, the clinical manifestations of furuncles caused by PVL-producing Staphylococcus aureus and the role of patients' background are not fully understood.
tected in !5% of S. aureus strains of clinical origin, and it is mainly associated with necrotic lesions of the skin and subcutaneous tissues, such as furuncles, and also with community-acquired, severe, necrotizing pneumonia [4, 5] . Recent findings suggest that severe pneumonia caused by PVL-producing S. aureus can occur in healthy children and young adults [6] .
Furuncles are acute, usually necrotic infections of hair follicles with S. aureus [7] . They primarily affect older children and young adults. The clinical presentation varies greatly, from a small follicular nodule to a large nodule, with various degrees of erythema, swelling, and central necrosis. Diabetes and immunosuppression are widely believed to predispose persons to furunculosis, although there is no available evidence that conclusively implicates factors that have been pro-posed as predisposing to furunculosis [8] . Although a strong association between furuncles and PVL-producing S. aureus has been observed, not all furuncles have been found to contain PVLproducing S. aureus. The characteristics of furuncles caused by PVL-producing S. aureus have not been clearly defined.
We investigated the prevalence of PVL gene-positive S. aureus among isolates recovered from various suppurative skin lesions, and we examined bacteriological markers of infection, including coagulase types, presence of the mecA gene, and toxin profiles. Also, we analyzed the cutaneous manifestations of and background characteristics of patients with PVL gene-positive strains, and we compared these findings with those for PVL gene-negative strains.
MATERIALS AND METHODS
Bacterial strains. We examined 161 strains of S. aureus isolated from various infective skin lesions at the Department of Dermatology, Okayama University Graduate School of Medicine and Dentistry (Okayama, Japan), and from community hospitals during the period of January 1997 through August 2002. The cutaneous samples were taken from primary and secondary skin infections. The types of infection included 40 cases of furuncles (including furunculosis), 20 cases of folliculitis, 20 cases of bullous impetigo, 11 cases of erysipelas (superficial cellulites), 9 cases of felon, 5 cases of pyoderma chronica, 7 cases of abscess, 7 cases of carbuncle, 20 cases of superficial secondary infections of various dermatoses (e.g., atopic dermatitis, eczema, and bullous disease), and 20 cases of deep secondary infections of various dermatoses (e.g., leg ulcer, decubitus, and burn).
The cutaneous manifestations and patient backgrounds of PVL gene-positive S. aureus furuncles were compared with those of PVL gene-negative S. aureus furuncles. The following data and clinical information were recorded for each case of furuncle: patient age, systemic or cutaneous underlying diseases, number of lesions (single or multiple), systemic symptoms (fever [temperature, 137.5ЊC] and lymphadenopathy), and local symptoms (erythema, swelling, and pain). Local symptoms were compared using the following scoring system. Erythema was categorized as follows: 1, slight (diameter, 0-3 cm); 2, moderate (diameter, 3-7 cm); and 3, high (diameter, 17 cm). Swelling was categorized as follows: 1, slight (diameter, 0-3 cm); 2, moderate (diameter, 3-7 cm); and 3, high (diameter, 17 cm). Pain was categorized as follows: 1, weak; and 2, strong.
All isolated S. aureus strains were initially cultured on sheep blood agar plates (Nissui) and Staphylococcus Medium No. 110 plates (Nissui). Strains were identified as S. aureus by their ability to coagulate rabbit plasma (Denka Seiken) and their ability to produce a clumping factor (Staphaurex; Meurex Diagnostics).
PVL gene detection by PCR. Genomic DNA was extracted on plates and was used as the template for amplification. The nucleotide sequence of the PVL gene is available at the GenBank data library (accession number, X 72700). The primer sequences for the PVL genes were as follows: luk-PV-1, 5 -ATCA-TTAGGTAAAATGTCTGGACATGATCCA-3 ; and luk-PV-2, 5 -GCATCAASTGTATTGGACATGATCCA-3 . After amplification for 30 cycles (30 s of denaturation at 94ЊC, 30 s of annealing at 45ЊC, and 1 min of extension at 72ЊC), the PCR products were resolved by electrophoresis on 2% agarose gels (Sigma), as described elsewhere [5] . Positive PCR products were identified by sequencing and comparison with X 72700 sequences.
Coagulase typing. The following method is commonly used to classify S. aureus strains for epidemiological survey in Japan. Each test strain was cultured in brain-heart infusion broth (BHI broth; Difco Laboratories) overnight with shaking, and the supernatant was recovered by centrifugation at 700 g. Then, 100 mL of the supernatant was placed in 9 test tubes, and 100 mL of anti-coagulase type I to VIII rabbit sera (Denka Seiken) was added to tubes 1-8. In the ninth tube, 100 mL of 5% normal rabbit serum was added as a control. These samples were incubated for 1 h at 37ЊC, and 200 mL of 10% normal rabbit plasma was then added to each tube. Then, these mixtures were again incubated at 37ЊC, and inhibition of plasma coagulation by the 8 specific serum samples was checked after 1, 2, 4, 6, and 24 h of incubation.
Detection of other toxins. Each test strain was cultured in BHI broth (Difco Laboratories) overnight with shaking. After centrifugation of each culture broth at 500 g for 20 min, 25 mL of the supernatant and 25 mL of 10-fold-diluted supernatant solutions were placed in 96-well tissue culture dishes (Becton Dickinson). Standard exotoxins and control latex sensitized by normal rabbit immunoglobulin G (IgG; Denka Seiken) were placed in separate wells as positive and negative controls, respectively. Latex particles (25 mL) coated with rabbit IgG specific for staphylococcal enterotoxins (SEA, SEB, SEC, and SED; Denka Seiken), exfoliative toxins (ETA and ETB; Denka Seiken) and toxic shock syndrome toxin-1 (TSST-1; Denka Seiken) were added to the culture wells. After 20 h of incubation at 37ЊC, the wells were checked for agglutination.
Susceptibility tests and mecA gene detection. The MIC of oxacillin (MPIPC; Sigma) for the S. aureus strains was determined using the broth microdilution method, in accordance with the guidelines of the Japanese Society for Chemotherapy. The mecA gene, which codes for methicillin resistance, was detected by PCR, as described by Murakami et al. [9] .
Statistical analysis. The disease distribution for PVL genepositive strains and the characteristics of PVL gene-positive and PVL gene-negative patients were compared using the x 2 test, Fisher's exact test, and the Mann-Whitney U test. P values of !.01 were considered to indicate statistical significance. 
RESULTS
Of the 161 strains examined, 20 (12.4%) strains were PVL producers (table 1) . PVL genes were detected in 16 (40%) of the 40 strains isolated from furuncles (the highest frequency among the disease types), 2 (28%) of the 7 strains isolated from carbuncles, 1 (14%) of the 7 strains isolated from abscesses, and 1 (5%) of the 20 strains isolated from folliculitis. None of the strains isolated from persons with impetigo, erysipelas, felon, pyoderma chronica, or secondary infections carried the PVL genes.
We were able to determine local symptoms for only 35 of the 40 cases of furuncles. Patients with PVL gene-positive furuncles were significantly younger than patients with PVL genenegative furunculosis ( ) and had no underlying systemic P ! .01 diseases (table 2). The underlying systemic diseases associated with PVL gene-negative furuncles were diabetes (3 patients), leukemia (2 patients), and other autoimmune diseases (2 patients). Atopic dermatitis was observed as an underlying cutaneous disease in both patients with PVL gene-positive and patients with PVL gene-negative furunculosis at a similar rate. Patients with PVL gene-positive strains had a higher tendency to develop multiple cutaneous furunculotic lesions than did those with PVL gene-negative strains. The erythema scores for patients with PVL gene-positive furuncles were significantly higher than those for patients with PVL gene-negative furuncles. However, there was no significant difference in swelling or pain between patients with PVL gene-positive and patients with PVL gene-negative furuncles.
Various coagulase types were observed in both groups (table  3) . Methicillin-resistant S. aureus (MRSA) was detected in 3 PVL gene-positive furuncles and 2 PVL gene-negative furuncles. The frequency of production of other toxins was low. There was no significant difference in production of toxins between PVL gene-positive and PVL gene-negative strains.
DISCUSSION
PVL gene-positive S. aureus is strongly associated with necrotic skin lesions and community-acquired necrotic pneumonia [4, 5] . Interestingly, the PVL gene has been rarely detected in S. aureus isolates recovered from patients with other infections, including impetigo, secondary skin infection, infective endocarditis, urinary tract infection, and hospital-acquired pneumonia [5] . In France, the PVL gene has been detected in 80%-93% of strains associated with furunculosis, 55% of strains associated with cellulites, and 36%-50% of strains associated with subcutaneous abscess [4, 5] . We found that PVL genepositive strains were isolated from furuncles and patients with furunculosis at rates of 40% and 67%, respectively. The relatively low rates of isolation of PVL gene-positive strains in Japan may be due to differences in geographic distribution of PVL gene-positive strains or differences in diagnostic criteria for furuncle. A study has shown that there are considerable differences in the prevalence and distribution of diseases associated with PVL between Europe and West Africa [10] . In that study, 30% of all S. aureus strains of clinical origin were found to produce PVL, with higher frequency for strains associated with genitourinary infections (43%) [10] . Additionally, the fact that there is a progression of severity from folliculitis to furuncle and the fact that both involve subepidermal growth of S. aureus in hair follicles [11] suggest that some of the subjects we describe with furuncle may have folliculitis.
In the present study, we also found that furuncles caused by PVL gene-positive S. aureus were usually multiple and were associated with more-intense erythema around the lesions, which may reflect strong inflammation caused by polymorphonuclear cells and capillary dilation [1] . It has previously been reported that there is a tendency for furunculosis to be caused by PVL gene-positive S. aureus. Couppie et al. [12] reported that 24 (92%) of 26 S. aureus strains isolated from persons with recurrent furunculosis produced PVL, whereas only 3 (33%) of 9 strains isolated from single furuncles produced PVL. PVL appears to be associated not only with development of the disease but also with communication of the strain. Additionally, in the present study, PVL gene-positive furuncles preferentially occurred in young adults and children without underlying systemic disease. Interestingly, the characteristics of these patients were the same as those of patients with typical furunculosis and are similar to some of the characteristics of patients with necrotizing pneumonia [6] caused by PVL gene-positive S. aureus.
The pathomechanism of furuncles is not fully understood. Although it has been demonstrated that S. aureus cells can invade hair follicles [13] , the mechanism of the disease after the invasion is unknown. Injection of purified PVL into rabbit skin has been shown to induce cutaneous necrotizing lesions, furuncle-like lesions caused by leukocytoclasis, and vascular necrosis [1] . Such PVL-induced histological changes and the available epidemiological data indicate that PVL is strongly associated with the development of furuncles as a factor of bacteria. Certain systemic disorders may predispose to furunculosis as host factors, including alcoholism, malnutrition, blood dyscrasias, neutrophil function disorders, iatrogenic conditions, immunosuppression (including AIDS), and diabetes [8] . However, there is no evidence available that conclusively implicates any of the proposed predisposing factors. The present findings regarding furuncles caused by PVL gene-negative strains suggest a relationship between furuncles and various systemic complications, including diabetes, leukemia, and autoimmune diseases.
Treatment protocols for patients with recurrent furunculosis have not been established. Initial therapy should consist of oral antibiotic therapy for 10-14 days [14] . However, additional lesions often develop after the end of each course of antibiotics. Nasal and perineal carriage of S. aureus should be eradicated. Topical antibacterial therapy, low-dose clindamycin therapy, or addition of rifampicin to the regimen may be helpful [15, 16] . Intravenous immunoglobulin could neutralize the effect of PVL [17] . It may be a strategy for severe PVL-associated furunculosis.
Recent studies have shown that the PVL locus is a stable genetic marker of community-acquired MRSA infection in France [18] and other countries [19] . However, PVL genepositive strains of S. aureus are not always MRSA. In one study, 14 of 83 PVL gene-positive strains were found to be community-acquired MRSA [18] . The present results show no significant difference in the prevalence of MRSA between PVL gene-positive furuncles and PVL gene-negative furuncles.
None of the patients with PVL gene-positive S. aureus we describe developed severe pneumonia or other systemic infection during the period of study. A case of community-acquired pneumonia and septicemia caused by PVL-producing S. aureus was reported in Japan [20] , but that patient did not have furuncles. However, PVL-producing S. aureus has previously been shown to cause septicemia and severe pneumonia in patients with furunculosis [6, 21] . Knowledge regarding the characteristics of furuncles caused by PVL gene-positive strains may be useful for prevention of the development of severe systemic infections.
In conclusion, the present results indicate that PVL genepositive S. aureus is closely associated with multiple erythematous furuncles of great intensity, particularly in young adults who do not have any underlying diseases. Additional epidemiological studies of PVL-producing S. aureus isolated from systemic infections in Japan and experimental studies to clarify the mechanism of furuncles are required.
